American Transit Sued Over Insurance Fraud Scheme
The insurer alleges a medical network billed for unnecessary treatments across more than 50 clinics.
Updated on Oct. 7, 2026 in Financial Crime
Live Poll
Do you believe large-scale medical insurance fraud contributes to higher auto insurance premiums for you?
American Transit Insurance Company filed a federal racketeering lawsuit alleging it was defrauded of over $3.3 million. The suit claims Atlantic Medical & Diagnostic, P.C. engaged in a systematic scheme involving medically unnecessary, predetermined treatments.
Why it matters
The lawsuit alleges that unlicensed individuals were effectively controlling the medical practice, rendering the network ineligible for no-fault insurance payments. This legal action seeks to halt further collections and recoup millions in damages.
American Transit filed the racketeering lawsuit in the Eastern District of New York on October 5, 2026. The insurer seeks $9.79 million in damages plus $1 million in punitive damages.
The players
American Transit Insurance Company
This is an insurance provider currently operating within the New York metropolitan area.
Atlantic Medical & Diagnostic, P.C.
This is a medical network that oversees a series of clinics accused of fraudulent insurance billing.
The details
The insurer claims the medical network utilized a standard 4-6 week treatment duration for all patients regardless of individual history. Furthermore, the network allegedly required ultrasound guidance for nearly every injection billed, a common feature in the examined claims.
Timeline
2021: GEICO filed a previous lawsuit against the network.
2024: Allstate and USAA filed separate lawsuits against the network.
July 2026: A court conference occurred before 500 new collection arbitrations.
October 5, 2026: American Transit filed its federal racketeering lawsuit.
Legal Context
The current litigation follows the pattern set by the 2021 GEICO lawsuit against Atlantic Medical & Diagnostic, which initiated a series of similar legal challenges by major insurers. Recent industry-wide efforts have focused on identifying standardized billing schemes across large medical networks.
This case may lead to increased scrutiny of no-fault insurance billing practices across clinics in the New York metropolitan area. Residents should remain aware that these legal proceedings are ongoing and may impact future insurance claim processing in the region.
The takeaway
This case highlights the recurring issue of standardized medical billing practices that ignore individual patient needs to maximize insurance payouts. Consumers are encouraged to carefully review their medical explanations of benefits for unusual billing patterns.
Further reading
For more on how local authorities monitor fraudulent activity, read the latest updates in Financial Crime.
Live Poll
Do you believe large-scale medical insurance fraud contributes to higher auto insurance premiums for you?
